Supremes bolster preemption defense

Share this article:

In a major test of the preemption principle, the US Supreme Court ruled 8-1 that patients can't file common-law claims challenging the safety and effectiveness of an FDA-approved medical device.

The case, Riegel v. Medtronic, involved a suit by the family of a man injured when a balloon catheter made by Medtronic burst while he was undergoing angioplasty after suffering a heart attack.

Writing for the majority, Justice Antonin Scalia said “Premarket approval is a ‘rigorous' process” that should preempt state laws.

The lone dissenter was Justice Ruth Bader Ginsburg.

Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.